175 related articles for article (PubMed ID: 16462536)
1. Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma.
Nam SW; Lee JH; Noh JH; Lee SN; Kim SY; Lee SH; Park CK; Ahn YM; Park WS; Yoo NJ; Lee JY
Eur J Gastroenterol Hepatol; 2006 Mar; 18(3):239-47. PubMed ID: 16462536
[TBL] [Abstract][Full Text] [Related]
2. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.
Nam SW; Park JY; Ramasamy A; Shevade S; Islam A; Long PM; Park CK; Park SE; Kim SY; Lee SH; Park WS; Yoo NJ; Liu ET; Miller LD; Lee JY
Hepatology; 2005 Oct; 42(4):809-18. PubMed ID: 16175600
[TBL] [Abstract][Full Text] [Related]
3. Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.
Rizzo F; Rinaldi A; Marchese G; Coviello E; Sellitto A; Cordella A; Giurato G; Nassa G; Ravo M; Tarallo R; Milanesi L; Destro A; Torzilli G; Roncalli M; Di Tommaso L; Weisz A
Oncotarget; 2016 Aug; 7(34):54650-54661. PubMed ID: 27429044
[TBL] [Abstract][Full Text] [Related]
4. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
[TBL] [Abstract][Full Text] [Related]
5. The cytological characteristics of small cell change of dysplasia in small hepatic nodules.
Chang O; Yano Y; Masuzawa A; Fukushima N; Teramura K; Hayashi Y
Oncol Rep; 2010 May; 23(5):1229-32. PubMed ID: 20372834
[TBL] [Abstract][Full Text] [Related]
6. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal alterations in hepatocellular nodules by comparative genomic hybridization: high-grade dysplastic nodules represent early stages of hepatocellular carcinoma.
Tornillo L; Carafa V; Sauter G; Moch H; Minola E; Gambacorta M; Vecchione R; Bianchi L; Terracciano LM
Lab Invest; 2002 May; 82(5):547-53. PubMed ID: 12003995
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis.
Jee BA; Choi JH; Rhee H; Yoon S; Kwon SM; Nahm JH; Yoo JE; Jeon Y; Choi GH; Woo HG; Park YN
Cancer Res; 2019 Nov; 79(21):5500-5512. PubMed ID: 31506333
[TBL] [Abstract][Full Text] [Related]
9. Alterations of p53, Bcl-2, and hMSH2 protein expression in the cirrhotic, macroregenerative, dysplastic nodules and hepatocellular carcinomas in Upper Egypt.
Hussein MR
Liver Int; 2004 Dec; 24(6):552-60. PubMed ID: 15566504
[TBL] [Abstract][Full Text] [Related]
10. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
[TBL] [Abstract][Full Text] [Related]
11. Dysplastic nodules frequently develop into hepatocellular carcinoma in patients with chronic viral hepatitis and cirrhosis.
Kobayashi M; Ikeda K; Hosaka T; Sezaki H; Someya T; Akuta N; Suzuki F; Suzuki Y; Saitoh S; Arase Y; Kumada H
Cancer; 2006 Feb; 106(3):636-47. PubMed ID: 16369988
[TBL] [Abstract][Full Text] [Related]
12. Latest developments in precancerous lesions of hepatocellular carcinoma.
Niu ZS; Niu XJ; Wang WH; Zhao J
World J Gastroenterol; 2016 Mar; 22(12):3305-14. PubMed ID: 27022212
[TBL] [Abstract][Full Text] [Related]
13. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNAs in Various Stages of Liver Disease Leading to Hepatocellular Carcinoma: Differential Expression of miRNAs, piRNAs, lncRNAs, circRNAs, and sno/mt-RNAs.
Koduru SV; Leberfinger AN; Kawasawa YI; Mahajan M; Gusani NJ; Sanyal AJ; Ravnic DJ
Sci Rep; 2018 May; 8(1):7967. PubMed ID: 29789629
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats.
Pérez-Carreón JI; López-García C; Fattel-Fazenda S; Arce-Popoca E; Alemán-Lazarini L; Hernández-García S; Le Berre V; Sokol S; Francois JM; Villa-Treviño S
Neoplasia; 2006 May; 8(5):373-83. PubMed ID: 16790086
[TBL] [Abstract][Full Text] [Related]
16. Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions.
Ojima H; Masugi Y; Tsujikawa H; Emoto K; Fujii-Nishimura Y; Hatano M; Kawaida M; Itano O; Kitagawa Y; Sakamoto M
Cancer Sci; 2016 Apr; 107(4):543-50. PubMed ID: 26797961
[TBL] [Abstract][Full Text] [Related]
17. Identification of genes associated with dedifferentiation of hepatocellular carcinoma with expression profiling analysis.
Midorikawa Y; Tsutsumi S; Taniguchi H; Ishii M; Kobune Y; Kodama T; Makuuchi M; Aburatani H
Jpn J Cancer Res; 2002 Jun; 93(6):636-43. PubMed ID: 12079511
[TBL] [Abstract][Full Text] [Related]
18. Atypical large well-differentiated hepatocellular carcinoma with benign nature: a new clinical entity.
Kudo M
Intervirology; 2004; 47(3-5):227-37. PubMed ID: 15383732
[TBL] [Abstract][Full Text] [Related]
19. Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a evidence for multistage progression.
Oda T; Tsuda H; Sakamoto M; Hirohashi S
Cancer Lett; 1994 Aug; 83(1-2):197-200. PubMed ID: 8062215
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity of chromosome 8p and 11p in the dysplastic nodule and hepatocellular carcinoma.
Kahng YS; Lee YS; Kim BK; Park WS; Lee JY; Kang CS
J Gastroenterol Hepatol; 2003 Apr; 18(4):430-6. PubMed ID: 12653892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
